ABACUS MEDICINE A/S — Credit Rating and Financial Key Figures
CVR number: 28111576
Kalvebod Brygge 35, 1560 København V
info@abacusmedicine.com
tel: 70220212
www.abacusmedicine.com
Income statement (mEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 420.10 | 558.97 | 671.13 | 675.31 | 832.25 |
| Costs of manufacturing | - 382.16 | - 512.96 | - 626.79 | - 615.69 | - 744.97 |
| External services | -12.85 | -17.62 | -14.20 | -14.15 | -22.76 |
| Gross profit | 25.09 | 28.39 | 30.13 | 45.47 | 64.52 |
| Employee benefit expenses | -13.57 | -15.13 | -15.90 | -22.28 | -29.90 |
| Other operating expenses | -4.10 | -0.48 | |||
| Total depreciation | -3.78 | -3.87 | -4.80 | -6.17 | -6.75 |
| EBIT | 3.63 | 8.91 | 9.43 | 17.01 | 27.86 |
| Other financial income | 0.32 | 0.13 | 0.48 | 0.86 | 4.05 |
| Other financial expenses | -2.57 | -3.21 | -3.84 | -4.97 | -10.76 |
| Net income from associates (fin.) | 0.86 | -4.30 | -4.09 | -4.36 | 3.67 |
| Pre-tax profit | 2.24 | 1.53 | 1.97 | 8.54 | 24.81 |
| Income taxes | -1.41 | -1.10 | -1.56 | -2.72 | -4.77 |
| Net earnings | 0.83 | 0.43 | 0.41 | 5.82 | 20.04 |
Assets (mEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 13.47 | 17.05 | 20.79 | 22.55 | 23.23 |
| Intangible assets total | 13.47 | 17.05 | 20.79 | 22.55 | 23.23 |
| Machinery and equipment | 0.74 | 0.67 | 0.51 | 0.37 | 0.18 |
| Other tangible assets | 1.31 | 0.58 | 5.32 | 4.17 | 3.40 |
| Tangible assets total | 2.05 | 1.25 | 5.83 | 4.54 | 3.58 |
| Holdings in group member companies | 4.68 | 20.46 | 17.68 | 15.78 | 21.02 |
| Investments total | 4.68 | 20.46 | 17.68 | 15.78 | 21.02 |
| Non-current other receivables | 0.76 | 0.13 | 0.04 | ||
| Long term receivables total | 0.76 | 0.13 | 0.04 | ||
| Inventories total | 67.78 | 95.39 | 90.56 | 98.74 | 169.64 |
| Current trade debtors | 37.57 | 32.42 | 37.78 | 38.30 | 68.34 |
| Short term receivables total | 37.57 | 32.42 | 37.78 | 38.30 | 68.34 |
| Cash and bank deposits | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash and cash equivalents | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance sheet total (assets) | 126.36 | 166.71 | 172.68 | 179.90 | 285.82 |
Equity and liabilities (mEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 0.51 | 0.51 | 0.52 | 0.52 | 0.52 |
| Other reserves | 2.04 | -0.04 | 0.57 | 1.32 | 1.17 |
| Retained earnings | 48.24 | 52.12 | 53.14 | 53.34 | 59.13 |
| Profit of the financial year | 0.83 | 0.43 | 0.41 | 5.82 | 20.04 |
| Shareholders equity total | 51.62 | 53.02 | 54.65 | 60.99 | 80.87 |
| Non-current leasing loans | 0.73 | 0.16 | 4.67 | 3.45 | 2.63 |
| Non-current other liabilities | 0.41 | 1.25 | 1.25 | 1.25 | 1.34 |
| Non-current deferred tax liabilities | 2.66 | 3.30 | 4.24 | 4.33 | 1.78 |
| Non-current liabilities total | 3.80 | 4.71 | 10.16 | 9.03 | 5.75 |
| Current leasing loans | 0.59 | 0.43 | 0.84 | 1.24 | 1.32 |
| Current trade creditors | 24.14 | 41.95 | 36.67 | 41.27 | 106.93 |
| Short-term deferred tax liabilities | 0.86 | 0.74 | 0.55 | 2.46 | 6.89 |
| Other non-interest bearing current liabilities | 41.11 | 59.85 | 65.69 | 60.67 | 78.67 |
| Current provisions | 4.24 | 6.01 | 4.13 | 4.26 | 5.39 |
| Current liabilities total | 70.94 | 108.98 | 107.88 | 109.89 | 199.20 |
| Balance sheet total (liabilities) | 126.36 | 166.71 | 172.68 | 179.90 | 285.82 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.